Doctor profile · Federal record

Dr. Mathew Meeneghan, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Bastrop, TX

  • NPI 1467695460
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 17 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3107 Highway 71 E
Bastrop, TX 786025158
(512) 308-9024
fax (512) 308-9074
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
April 2009 — 17 yrs on file
Profile last updated
January 20, 2022
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
Texas #Q3236 · North Carolina #2012-00461
Medicaid (2)
TX #347164101 · TX #347164102

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1467695460. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
92,827
Distinct HCPCS
10
Medicare allowed
$1,337,168
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 34,170 34 $0
J9271 Injection, pembrolizumab, 1 mg 12,400 19 $54
J1756 Injection, iron sucrose, 1 mg 10,700 23 $0
J1453 Injection, fosaprepitant, 1 mg 6,750 14 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 5,330 17 $3
J0897 Injection, denosumab, 1 mg 2,400 17 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,173 73 $0
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 2,150 14 $42
J9041 Injection, bortezomib, 0.1 mg 1,750 15 $5
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,709 436 $8

In context: peer comparison

Among 2 peers in Bastrop Hematology & Oncology Physician, average services per provider: 1,402. This provider delivers 66× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,181
Transactions
47
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 6 $250.09
Janssen Biotech, INC. 12 $153.53
Pfizer INC. 6 $126.00
Novartis Pharmaceuticals Corporation 5 $107.84
E.R. Squibb & Sons, L.L.C. 3 $73.15
Eisai INC. 3 $59.72
Lilly USA, LLC 2 $44.91
Merck Sharp & Dohme LLC 2 $39.99
Takeda Pharmaceuticals U.S.A., INC. 2 $38.46
Abbvie INC. 1 $36.95
Apellis Pharmaceuticals, INC. 1 $30.29
Gilead Sciences, INC. 1 $26.48
Adaptive Biotechnologies Corporation 1 $25.87
Tempus Ai, INC 1 $23.05
Sobi, INC 1 $20.54

By nature of payment

Food and Beverage
$1,134
Education
$47

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
851
Patients
259
Total drug cost
$1,146,651
Drug Type Claims Patients Total cost
Anastrozole Generic 106 32 $2,799
Letrozole Generic 81 24 $1,956
Eliquis (Apixaban) Brand 73 15 $56,515
Dexamethasone Generic 63 20 $788
Potassium Chloride Generic 59 17 $1,502
Xarelto (Rivaroxaban) Brand 59 13 $45,817
Ondansetron Odt (Ondansetron) Brand 58 29 $653
Prednisone Generic 55 18 $352
Gabapentin Generic 53 12 $1,060
Oxycodone Hcl Generic 49 22 $889

Frequently asked questions

Auto-generated from federal data
What is Dr. Mathew Meeneghan's medical specialty?
Dr. Mathew Meeneghan practices Hematology & Oncology Physician in Bastrop, TX.
Where does Dr. Mathew Meeneghan practice?
Dr. Mathew Meeneghan practices at 3107 Highway 71 E, Bastrop, TX 786025158. Office phone: 5123089024.
What is Dr. Mathew Meeneghan's NPI?
Dr. Mathew Meeneghan's National Provider Identifier (NPI) is 1467695460, issued by NPPES.
Does Dr. Mathew Meeneghan accept Medicare assignment?
Yes. Dr. Mathew Meeneghan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mathew Meeneghan commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, iron sucrose, 1 mg (HCPCS J1756). Source: CMS Medicare Physician & Other Practitioners file.